Ameriprise Financial Inc Biogen Inc. Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Biogen Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 798,660 shares of BIIB stock, worth $185 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

798,660

Previous 202,487 294.43%

Holding current value

$185 Million

Previous $52.4 Million 228.67%

% of portfolio

0.05%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $126 Million - $160 Million	596,173 Added 294.43%	798,660 $172 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $3.53 Million - $4.25 Million	-15,878 Reduced 7.27%	202,487 $52.4 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $4.97 Million - $5.61 Million	19,638 Added 9.88%	218,365 $56.1 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $3.33 Million - $3.85 Million	-12,113 Reduced 5.75%	198,727 $56.6 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $22.3 Million - $25.4 Million	86,919 Added 70.14%	210,840 $58.6 Million

Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $949,174 - $1.15 Million	3,760 Added 3.13%	123,921 $34.3 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $113,114 - $155,975	-581 Reduced 0.48%	120,161 $32.2 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $7.15 Million - $8.5 Million	-38,111 Reduced 23.99%	120,742 $24.5 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $99.2 Million - $125 Million	-512,072 Reduced 76.32%	158,853 $32.8 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $65 Million - $83.5 Million	290,289 Added 76.26%	670,925 $160 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $54.1 Million - $70.6 Million	191,227 Added 100.96%	380,636 $108 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $2.2 Million - $3.53 Million	-8,513 Reduced 4.3%	189,409 $65.6 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $24 Million - $28.1 Million	98,756 Added 99.59%	197,922 $55.4 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $6.56 Million - $9.88 Million	-27,783 Reduced 21.89%	99,166 $24.3 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $163,627 - $188,928	618 Added 0.49%	126,949 $36 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $14.2 Million - $18.8 Million	-54,918 Reduced 30.3%	126,331 $33.7 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $3.91 Million - $4.96 Million	-14,530 Reduced 7.42%	181,249 $57.3 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $5.6 Million - $7.74 Million	-25,443 Reduced 11.5%	195,779 $58.1 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $7.31 Million - $8.2 Million	-33,624 Reduced 13.19%	221,222 $51.5 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $71.7 Million - $79 Million	-327,010 Reduced 56.2%	254,846 $59.2 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $350 Million - $548 Million	-1,615,629 Reduced 73.52%	581,856 $137 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $164 Million - $208 Million	-588,438 Reduced 21.12%	2,197,485 $661 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $2.47 Million - $3.23 Million	8,418 Added 0.3%	2,785,923 $1.06 Billion
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $44.2 Million - $52.7 Million	171,656 Added 6.59%	2,777,505 $806 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $415,427 - $587,552	-1,597 Reduced 0.06%	2,605,849 $714 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $91.7 Million - $103 Million	298,052 Added 12.91%	2,607,446 $831 Million
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $649 Million - $761 Million	2,309,394	2,309,394 $723 Million

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Biogen Inc. Transaction History